Endometrial
BNT323-01 (Fern-EC-01)
A Phase III, randomized, multi-site, open-label trial of BNT323/DB-1303 versus investigator’s choice of chemotherapy in previously treated patients with HER2- expressing recurrent endometrial cancer
Trial overview
Clinical Area
Medical Oncology
Disease
Endometrial cancer
Disease site
Gynaecology
Study Phase
III
Trial Identifiers
Registration number: NCT06340568
GenesisCare Location(s)
Principal Investigator(s)